Semaglutide vs Tirzepatide: Which Is Right for You?

If you only remember one thing: tirzepatide produced more weight loss than semaglutide in the trials, but "more" is not automatically "right for you." Price, dosing, side-effect tolerance, and how your body responds all bend the decision. Here is the evidence, stated plainly, then how to choose.

What each molecule is

Semaglutide is a GLP-1 receptor agonist — it mimics one gut hormone that curbs appetite and slows gastric emptying. Tirzepatide is a dual agonist: it hits both the GLP-1 and GIP receptors. That second mechanism is the leading explanation for why tirzepatide tends to drive more weight loss.

The efficacy evidence

The cleanest way to read the numbers is trial by trial.

Semaglutide, in the STEP-1 obesity trial, produced a mean body-weight reduction of roughly 15% over 68 weeks at the 2.4 mg weekly dose¹. That result underpins the FDA approval of Wegovy for chronic weight management².

Tirzepatide, in SURMOUNT-1, went further: about 15% at 5 mg, and roughly 20–21% at the 15 mg dose over 72 weeks³. That result underpins the FDA approval of Zepbound⁴.

The most direct comparison comes from SURPASS-2, a head-to-head trial in adults with type 2 diabetes. There, tirzepatide beat semaglutide 1 mg on both blood-sugar control and weight reduction⁵. It is a diabetes trial rather than an obesity trial, so read it as directional for weight — but the direction is consistent: tirzepatide tends to win on magnitude. Magnitude is not the only number worth tracking, though: body-composition substudies show a real share of that loss on either molecule is lean mass, not fat — see how much muscle you actually lose on a GLP-1 for the DXA-measured numbers side by side.

So why would anyone pick semaglutide?

Because raw magnitude is one variable, not the only one.

**Price.** In our ranking, compounded semaglutide is frequently the cheaper molecule, and for many people the gap funds months of treatment. See what compounded GLP-1 costs per month, or price the two against each other over your own horizon in the cost calculator.

**Track record.** Semaglutide has been in widespread use longer, which some people weigh heavily.

**Tolerability.** Both cause GI side effects — nausea, constipation — that ease with slow titration. Individuals tolerate the two differently; the "better" molecule is partly the one your body handles. The two escalation schedules are not the same length either: semaglutide reaches its recommended maintenance dose at week 17, while tirzepatide's top dose is 21 weeks away on the label's minimum intervals. Our escalation planner lays both schedules out week by week, against the billing months they land in.

**Availability.** Depending on your provider and state, one molecule may simply be easier to get.

**A specific medical indication.** Tirzepatide is the only one of the two with an FDA-approved indication for obstructive sleep apnea alongside weight management — worth knowing if that is part of your reason for treatment. Whichever molecule you are weighing, confirm you actually meet the label's eligibility criteria first; both share the same hard exclusions.

How to choose

Choose **tirzepatide** if maximum weight loss is the priority, the price premium is acceptable, and you tolerate titration well. It is the stronger performer on the trial evidence — and if that is where you land, our ruling on the tirzepatide sellers names both the ones we would use and the three we would not.

Choose **semaglutide** if cost is decisive, you prefer the longer-established option, or your provider prices it more aggressively. It is a proven, powerful drug in its own right — STEP-1's ~15% is not a consolation prize.

And remember you are not married to the choice: the best move is often to start on one and keep the option to switch, including if you plateau on one and want to try the other. Providers with both molecules on a single account make that painless — which is exactly why formulary breadth is a scored factor in our Verdict Score methodology. Watch what the switch costs, too: Trellis Vitality prices both molecules in one published table at $150 and $199 a month with every dose the same price, which is the shape that makes changing your mind cheap rather than a renegotiation. Compare who offers what in the reviews, and if you are still deciding between compounded and brand, read how the compounded and brand-name routes actually differ.

This is editorial information, not medical advice. Which molecule and dose is right for you is a decision for you and a licensed clinician.